AVXS-101 Phase 1 Gene Therapy Clinical Trial in Spinal Muscular Atrophy Type 1 (SMA1): Event-free Survival and Achievement of Developmental Milestones

被引：0
|
作者：
Mendell, J.
Al-Zaidy, S.
Shell, R.
Arnold, W.
Rodino-Klapac, L.
Prior, T.
Lowes, L.
Alfano, L.
Berry, K.
Church, K.
Kissel, J.
Nagendran, S.
L'Italien, J.
Sproule, D.
Wells, C.
机构：
来源：
ANNALS OF NEUROLOGY | 2018年 / 84卷
关键词：
Neuromuscular Disorders; Genetics; Rare Diseases;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
136
引用
收藏
页码：S387 / S388
页数：2
相关论文
共 50 条
  • [1] AVXS-101 phase 1 gene therapy clinical trial in spinal muscular atrophy type 1: event-free survival and achievement of developmental milestones
    Mendell, J.
    Al-Zaidy, S.
    Shell, R.
    Arnold, W.
    Rodino-Klapac, L.
    Prior, T.
    Lowes, L.
    Alfano, L.
    Berry, K.
    Church, K.
    Kissel, J.
    Nagendran, S.
    Italien, J. L.
    Sproule, D.
    Wells, C.
    Burghes, A.
    Foust, K.
    Meyer, K.
    Likhite, S.
    Kaspar, B.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S81 - S81
  • [2] AVXS-101 phase 1 gene replacement therapy clinical trial in spinal muscular atrophy type 1 (SMA1): 24-month event-free survival and achievement of developmental milestones
    Mendell, J. R.
    Al-Zaidy, S.
    Shell, R.
    Arnold, W. D.
    Rodino-Klapac, L.
    Prior, T. W.
    Lowes, L. P.
    Alfano, L. N.
    Berry, K.
    Church, K.
    Kissel, J. T.
    Nagendran, S.
    L'Italien, J.
    Sproule, D. M.
    Wells, C.
    Burghes, A. H. M.
    Foust, K. D.
    Meyer, K.
    Likhite, S.
    Kaspar, B. K.
    HUMAN GENE THERAPY, 2018, 29 (12) : A22 - A22
  • [3] AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones
    Mendell, Jerry R.
    Al-Zaidy, Samiah
    Shell, Richard
    Arnold, W. Dave
    Rodino-Klapac, Louise
    Prior, Thomas W.
    Lowes, Linda
    Alfano, Lindsay
    Berry, Katherine
    Church, Kathleen
    Kissel, John T.
    Nagendran, Sukumar
    L'Italien, James
    Sproule, Douglas M.
    Wells, Courtney
    Burghes, Arthur H. M.
    Foust, K. D.
    Meyer, Kathrin
    Likhite, Shibi
    Kaspar, Brian K.
    MOLECULAR THERAPY, 2018, 26 (05) : 30 - 30
  • [4] AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Event Free Survival and Achievement of Developmental Milestones
    Mendell, Jerry
    Al-Zaidy, Samiah
    Shell, Richard
    Arnold, W. Dave
    Rodino-Klapac, Louise
    Prior, Thomas
    Lowes, Linda
    Alfano, Lindsay
    Berry, Katherine
    Church, Kathleen
    Kissel, John
    Nagendran, Sukumar
    L'Italien, James
    Sproule, Douglas
    Wells, Courtney
    Du, Minna
    Cardenas, Jessica
    Burghes, Aurthur
    Foust, K. D.
    Meyer, Kathrin
    Likhite, Shibi
    Kaspar, Brian
    MOLECULAR THERAPY, 2017, 25 (05) : 137 - 137
  • [5] AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Event Free Survival and Achievement of developmental milestones
    Mendell, Jerry
    Al-Zaidy, Samiah A.
    Shell, Richard
    Arnold, W. David
    Rodino-Klapac, Louise R.
    Prior, Thomas W.
    Lowes, Linda
    Alfano, Lindsay N.
    Berry, Katherine
    Church, Kathleen
    Kissel, John
    Nagendran, Sukumar
    L'Italien, James
    Sproule, Doug M.
    Du, Minna
    Cardenas, Jessica A.
    Burghes, Arthur
    Foust, Kevin D.
    Meyer, Kathrin
    Likhite, Shibi
    Kaspar, Brian K.
    NEUROLOGY, 2017, 88
  • [6] AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Continued Event Free Survival and Achievement of Developmental Milestones
    Mendell, Jerry
    Al-Zaidy, Samiah
    Shell, Richard
    Arnold, W. Dave
    Rodino-Klapac, Louise
    Prior, Thomas
    Lowes, Linda
    Alfano, Lindsay
    Berry, Katherine
    Church, Kathleen
    Kissel, John
    Nagendran, Sukumar
    L'Italien, James
    Sproule, Douglas M.
    Wells, Courtney
    Burghes, Arthur
    Foust, Kevin D.
    Meyer, Kathrin
    Likhite, Shibi
    Kaspar, Brian
    NEUROLOGY, 2018, 90
  • [7] AVXS-101 phase 1 gene therapy clinical trial in SMA Type 1: end-of-Study event free survival and achievement of developmental milestones
    Mendell, J.
    Al-Zaidy, S.
    Shell, R.
    Arnold, W.
    Rodino-Klapac, L.
    Prior, T.
    Lowes, L.
    Alfano, L.
    Berry, K.
    Church, K.
    Kissel, J.
    Nagendran, S.
    L'Italien, J.
    Sproule, D.
    Wells, C.
    Burghes, A.
    Foust, K.
    Kaspar, B.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S208 - S208
  • [8] AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Continued Event-Free Survival, Achievement of Developmental Milestones, and Continued Respiratory and Nutritional Support Independence
    Shell, R.
    Al-Zaidy, S.
    Kotha, K.
    Arnold, W.
    Rodino-Klapac, L.
    Prior, T.
    Lowes, L.
    Alfano, L.
    Berry, K.
    Church, K.
    Kissel, J.
    Nagendran, S.
    L'Italien, J.
    Sproule, D.
    Wells, C.
    Burghes, A.
    Foust, K.
    Meyer, K.
    Likhite, S.
    Kaspar, B.
    Mendell, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] AVXS-101 phase-1 gene replacement therapy clinical trial in SMA type-1: continued event free survival and achievement of developmental milestones
    Al-Zaidy, S.
    Shell, R.
    Arnold, W.
    Rodino-Klapac, L.
    Prior, T.
    Lowes, L.
    Alfano, L.
    Berry, K.
    Church, K.
    Kissel, J.
    Nagendran, S.
    L'Italien, J.
    Sproule, D.
    Wells, C.
    Burghes, A.
    Foust, K.
    Meyer, K.
    Likhite, S.
    Kaspar, B.
    Mendell, J. R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 62 - 62
  • [10] AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Ventilation Support Free Survival and Achievement of Developmental Milestones
    Al-Zaidy, S.
    Shell, R.
    Arnold, W. D.
    Rodino-Klapac, L.
    Prior, T.
    Lowes, L.
    Alfano, L.
    Berry, K.
    Church, K.
    Kissel, J.
    Nagendran, S.
    L'Italien, J.
    Sproule, D.
    Wells, C.
    Du, M.
    Cardenas, J.
    Burghes, A.
    Foust, K.
    Meyer, K.
    Likhite, S.
    Kaspar, B.
    Mendell, J.
    ANNALS OF NEUROLOGY, 2017, 82 : S263 - S264
12345